Expert Review of Recent Health System Specialty Pharmacy Research Studies, Part 2

In this 2-part CE webinar series, pharmacists and pharmacy technicians will learnabout the design and findings of four research studies that evaluated how fully-integratedhealth system specialty pharmacy services impact patient care and clinical outcomes.

Fertility Module #3: Infertility: Protocols and Patient Management

Module 3 reviews the appropriate pharmacological and non-pharmacological protocols typically used to address infertility. The medications used in a typical assisted reproductive therapy course will also be presented. Available for free to NASP members. Visit www.ProCE.com/CSPE

Fertility Module #4: Fertility Care Considerations: Special Populations and Considerations

Module 4 will conclude with addressing some of the special considerations in patients with infertility issues. Future trends in assisted reproductive technology will also be presented. Available for free to NASP members. Visit www.ProCE.com/CSPE

Growth Hormone Deficiency

The purpose of this CE is to give technicians an overview of growth hormone deficiency (GHD) in children and adults in order to better understand and engage this patient population. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

Hemophilia in Specialty Pharmacy

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #1: The abCs of HCV

Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #3: HCV Drug Therapy Management

Module Three will address patient specific factors, treatment options, and the monitoring of HCV treatments. Pharmacist interventions will also be discussed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy

Module Four will include appropriateness of therapy for special populations, resistance issues, and emerging treatment options. The role of the specialty pharmacist will also be addressed. This activity is available for free to NASP members. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C: A Technician’s Guide

Technicians will learn about the presentation, prevalence, and risk factors for contracting hepatitis C virus (HCV). HCV prognosis, goals of therapy, and guideline-recommended treatment options will be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.